| GC60763-10mg |
|
1263303-95-2 |
|
0 |
— |
|
|
|
| GC60763-5mg |
|
1263303-95-2 |
|
0 |
— |
|
|
|
| GC60762-1mg |
|
183668-52-2 |
|
0 |
— |
|
|
|
| GC60761-1mg |
|
862694-97-1 |
|
0 |
— |
|
|
|
| GC60760-250mg |
|
2292116-14-2 |
Desmorpholinyl Quizartinib-PEG2-COOH
|
0 |
— |
|
|
|
| GC60760-50mg |
|
2292116-14-2 |
Desmorpholinyl Quizartinib-PEG2-COOH
|
0 |
— |
|
|
|
| GC60759-100mg |
|
2365172-82-1 |
Desmorpholinyl Navitoclax-NH-Me
|
0 |
— |
|
|
|
| GC60759-50mg |
|
2365172-82-1 |
Desmorpholinyl Navitoclax-NH-Me
|
0 |
— |
|
|
|
| GC60759-10mg |
|
2365172-82-1 |
Desmorpholinyl Navitoclax-NH-Me
|
0 |
— |
|
|
|
| GC60759-5mg |
|
2365172-82-1 |
Desmorpholinyl Navitoclax-NH-Me
|
0 |
— |
|
|
|
| GC60759-10mM (in 1mL DMSO) |
|
2365172-82-1 |
Desmorpholinyl Navitoclax-NH-Me
|
0 |
— |
|
|
|
| GC60758-100mg |
|
1977-07-7 |
|
0 |
— |
|
|
|
| GC60758-50mg |
|
1977-07-7 |
|
0 |
— |
|
|
|
| GC60758-10mg |
|
1977-07-7 |
|
0 |
— |
|
|
|
| GC60758-10mM (in 1mL DMSO) |
|
1977-07-7 |
|
0 |
— |
|
|
|
| GC60757-5mg |
|
355841-11-1 |
|
0 |
— |
|
|
|
| GC60757-1mg |
|
355841-11-1 |
|
0 |
— |
|
|
|
| GC60756-5mg |
|
103302-15-4 |
D-Erythrose 4-phosphate sodium
|
0 |
— |
|
|
|
| GC60755-1mg |
|
989-23-1 |
|
0 |
— |
|
|
|
| GC60754-1mg |
|
963-39-3 |
|
0 |
— |
|
|
|
